World on alert
as bird flu (H5N1 virus) reaches Europe
For the last two months health authorities and government leaders
around the globe have been holding hastily arranged cabinet meetings
and medical conferences in a desperate attempt to prepare for what
many fear is an inevitable influenza pandemic that the world is
ill prepared to cope with. As communicable disease experts carefully
scrutinize daily medical reports for the first signs of the impending
pandemic, public health specialists and manufacturers are working
frantically to develop vaccines, drugs, and strategies to quarantine
and treat the ill. Unfortunately, all of these plans will take
several years to implement, and the most dangerous strain of influenza
to appear in decades -- the H5N1 "bird flu" in Asia --
is showing up in new populations of birds, and occasionally people,
on an almost daily basis.
Driving this unparalleled level of international cooperation is
the simple fact that a global influenza pandemic has nothing in
common with the relatively mild forms of flu that appear every
year. Common influenza is caused by well-known strains of flu that
have circulated through the human population for decades or longer.
Since humans already possess broad immunity to these garden-variety
strains, they can only cause reinfection by slightly altering their
genes from year to year, usually resulting in only mild discomfort.
Pandemic influenza, on the other hand, is a rare and deadly form
of virus that can only arise after a new strain from an animal
source mixes its genes with a common human bug to produce a completely
new strain that is highly contagious, extremely deadly, and to
which people have absolutely no prior immunity
Thankfully, flu pandemics are relatively rare – only four occurred
in all of the 20th century. But given that it has been more than 40 years
since the last pandemic many health experts believe that the time is
ripe for a new outbreak. Such concerns are heightened by the rapid spread
of a new contagious microbe known as influenza H5N1, or avian (bird)
flu. After first being detected in wild birds in Asia, avian flu has
recently passed through Siberia, into Rumania, and is now moving across
Europe.
So far the human death toll from avian flu has been low, and confined
to people in close contact with infected birds. But a number of scientists
are warning of a major pandemic if the H5N1 virus mutates into a form
capable of being transmitted between humans. "Every time a new person
gets infected with the virus there is a small chance that person will
trigger a pandemic," said Neil Ferguson, a scientist at London’s
Imperial College who has been running simulations to predict what will
happen when H5N1 to reach Britain. And while some scientists believe
the chances are low, researchers discovered that the strain of H5N1 isolated
in Rumania has already mutated into a version that is more easily transmitted
to humans. Adding to the bad news, medical authorities in Asia recently
reported of a case where they believe H5N1 was passed from one person
to another.
Global Medical Community not Prepared for Pandemic
The "Spanish flu" pandemic of 1918 killed an estimated
100 million people. If such an outbreak were to occur today many
health experts predict that the combination of increased population
density (3 times higher than in 1918) and rapid global travel could
spread the virus across the globe in a matter of days and make
containment almost impossible. The problem would be further exacerbated
by the shortage of effective antiviral drugs and vaccines. According
to even the most optimistic estimates, current supplies of vaccines
and drugs are far too low to control a major outbreak, let alone
contain a full-fledged global pandemic.
Writing in the July 31, 2005 Washington Post, reporter David Brown
points out that “if the virus were to start spreading in
the next year, the world would have only a relative handful of
doses of an experimental vaccine to defend against a disease that,
history shows, could potentially kill millions. If the vaccine
proved effective and every flu vaccine factory in the world started
making it, the first doses would not be ready for four months.
By then, the pathogen would probably be on every continent. Theoretically,
antiviral drugs could slow an outbreak and buy time. The problem
is only one licensed drug, oseltamivir (Tamiflu), appears to work
against bird flu. At the moment, there is not enough stockpiled
for widespread use. Nor is there a plan to deploy the small amount
that exists in ways that would have the best chance of slowing
the disease.”
Currently there is no vaccine that can protect against the H5N1
avian flu virus because scientists do not yet know what the final
strain will be. According to The Guardian some manufacturers are
working on general H5N1 vaccines which they hope would provide
some protection in the event of a pandemic, but these remain unproven.
Making matters even worse, a new strain of the bird flu virus recently
isolated from an infected Vietnamese girl has been determined to
be resistant to Tamiflu, the aforementioned drug that health officials
are counting on to combat an avian influenza pandemic.
In light of a lack of adequate treatments, U.S. public health
specialists are drawing up unprecedented countermeasures to slow
the spread of a pandemic, including vaccinating only children;
mandatory closing of schools or office buildings; and imposing
quarantines on infected families to prohibit them from leaving
their homes. And around the globe authorities are drafting similar
drastic measures to contain an outbreak, including restricting
international travel, shutting down public transit systems and
nationalizing supplies of critical medical equipment, such as surgical
masks.
Herbal Formula Effective in Hong Kong Health Crisis
While Western health experts and drug companies try to cope with
a lack of vaccines and antiviral drugs, emergency health authorities
in China have been quietly stockpiling a unique anti-viral herbal
formula that has already been shown to be effective for protecting
those at highest risk of infection during a viral outbreak — the
front-line doctors and nurses who risk their lives to control the
outbreak. When SARS first appeared in Hong Kong in March 2003,
the disease proved incredibly difficult to treat. Antibiotics and
standard antiviral drugs, including a powerful combination of the
anti-viral drug ribavirin and steroids, turned out to be totally
ineffective. Compounding the SARS crisis was the alarming discovery
that front-line healthcare workers were especially vulnerable — up
to 25% of all cases were the very doctors and nurses caring for
the ill.
Confronted with a deadly, highly virulent virus that was resistant
to conventional treatments, Hong Kong health authorities desperately
sought out any means for treating the new disease. Then in mid-April
officials noted a curious anomaly — even as doctors and nurses
at Western-style hospitals continued to become sick, their medical
peers staffing the traditional Chinese medicine clinics throughout
Hong Kong were remaining healthy and infection-free despite working
in close proximity to infected patients. As the authorities quickly
learned, the clinic workers were boosting their immune systems
to prevent infection by taking a unique antiviral herbal formula
that had been produced by medical experts at the city’s Chinese
University.
Within days hospital authorities had rushed 40,000 doses of the
formula to at-risk health care workers across the city, while a
special team of epidemiologists from the University of Hong Kong
monitored the workers to track their exposure to the virus. After
two weeks the researchers reported the blood samples revealed that
not even a single health worker had contracted the infection after
taking the herbal formula. Additionally, the blood samples showed
that the formula was significantly boosting the workers immunological
functions, indicating an ability to prevent viral infection at
the very earliest stages of exposure. The epidemiological team
concluded that their evaluation indicated that the herbal formula
was a suitable preparation for preventing influenza-like infections.
Natural Antiviral Herbal Support for Colds and Flu
The formula used in Hong Kong was based on the work of one of
the leading experts of modern Chinese medicine (and the inventor
of Vital Cell), Dr. Dexin Yan. In 1990 Dr. Yan launched an intensive
study of the effects of three traditional cold and flu formulas.
The first, Yin Chiao, was shown to be effective for stopping a
cold if taken at the first sign of an infection. The second formula,
Gan Mao Ling, was found to significantly reduce the duration of
a cold or flu if taken after infection had already set in. And
the last formula, Zhong Gan Ling, turned out to be extremely effective
for treating the flu, especially when present with a high fever.
Dr. Yan combined the best elements of all three formulas. Additionally,
he increased the amount of three important medicinal herbs, ilex,
isatis, and forsythia, that new research has shown exert powerful,
antiviral actions. Dr. Yan then went to the next step, adding elements
from a fourth formula, Pe Min Kan Wan, which acts as an effective
nasal decongestant.
After extensive testing and clinical evaluation to determine the
precise percentage of each herbal ingredient, Dr. Yan finally arrived
at a single formula that stops colds or flu when taken at the first
sign, and speeds up recovery when taken after a cold or flu has
already started. Best of all, reports from Dr. Yan’s patients
revealed that the formula was especially effective at alleviating
such common symptoms as nasal congestion, headaches and stuffy
head symptoms, without the side effects of over-the-counter medications.
Anti-Viral
Formula now Available in the United States
Dr. Yan’s formula is now available in the U.S. as ImmunoPhase.
Unlike over-the-counter cold and flu medications that cover up
and/or suppress the miserable symptoms of a cold or flu, ImmunoPhase
offers a powerful, proactive response to colds and flu. By enhancing
the immune system during the first signs of infection, ImmunoPhase
aids in repelling the virus before it has a chance to spread. And
in addition to being highly effective at preventing illness when
taken at the first signs of an impending cold or flu, ImmunoPhase
has also been shown to relieve symptoms and enhance the immune
system for a more rapid recovery when taken after one has already
caught a cold or flu.
ImmunoPhase Ingredients and Actions
- Angelica root – nasal/sinus congestion,
headache
- Artemesia plant – fever
- Forsythia fruit – sore throat, fever,
headache
- Gypsum fiber – high fever, irritability,
thirst, cough, wheezing
- Honeysuckle flower – sore throat, headache,
fever, antiviral, antibacterial
- Ilex root – antitussive and expectorant
for coughs, fever, headache, antiviral
- Isatis root – painful, swollen throat,
antibacterial, antiviral
- Magnolia flower – nasal/sinus congestion
- Notopterygii root and rhizome – chills,
fever, headache, body aches
- Pueraria root – fever, headache, stiff
neck, thirst
- Verbenae stem and leaf – swollen throat
- Xanthii fruit – opens nasal passages,
nasal/sinus discharge, headache
Dosage and Safety of ImmunoPhase
ImmunoPhase™ is an advanced herbal formula that offers effective
immune support for fighting off colds and flu. ImmunoPhase is completely
free of side effects and use will not make one feel sleepy, cause
drowsiness or otherwise impair function. Since the formula is stimulant-free
its use does not contribute to irritability, impair sleep or interfere
with blood pressure medications [as might compounds containing
pseudoephedrine].
Adults: At the first signs of a cold or flu,
take two capsules every 2-3 hours
Children age 6-12: Take one capsule every 3 hours
at the first sign of a cold or flu.
When taken after cold or flu have already developed, continue
with the recommended dosage to reduce symptoms and speed recovery.
ImmunoPhase, 60 caps……………$24.95
Order
ImmunoPhase Now…
|